Cutler Adam D. — SEC Form 4 filings

SEC reporting owner CIK 1722673. 4 Form 4 filings on record with FilingPulse; latest filed 2025-12-05.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-11-01 to 2025-12-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mural Oncology plc (MURA)Chief Financial Officer42 legs · 14,569 sh · $40,2455

Form 4 filings — Cutler Adam D.

FiledFormIssuerReported transactionsSource
2025-12-054Mural Oncology plc (MURA)Disposition to issuer (D): 99,290 · Disposition to issuer (D): 146,452 (derivative) · Disposition to issuer (D): 65,000 (derivative)EDGAR
2025-11-104Mural Oncology plc (MURA)Sale (S): 7,148 @ $2.09EDGAR
2025-03-054Mural Oncology plc (MURA)Grant/award (A): 35,000 @ $0 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-11-014Mural Oncology plc (MURA)Sale (S): 7,421 @ $3.41EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722673 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →